NEW YORK (GenomeWeb News) – Uppsala, Sweden-based Olink Bioscience has allied with Beijing Pioneer Medical Instrument (PioneerBiomed) to distribute its protein research technology in China.
Under the agreement, PioneerBiomed will distribute Olink Bioscience's Duolink product line to its clients in academic, clinical, and government labs, and to biotechnology and pharmaceutical customers.
The Duolink line uses the firm's in situ proximity ligation assay technology to extend the capabilities of protein applications to include direct detection of proteins, protein interactions, and modifications. The technology enables researchers to detect target proteins at single-molecule resolution and to study them at normal expression levels in fixed cells and tissue sections.
Olink Biosciences Director of Sales and Marketing Peter Karlberg said that the distribution pact "represents a huge commercial opportunity" that will "bring us valuable new business in the academic and the biotech/pharmaceutical industry throughout the country."